ICU Trials by ClinCalc

Review by eFreeware

ICU Trials by ClinCalc is a paid medical reference for critical care clinicians, built around summaries of landmark trials rather than full texts. It comes from ClinCalc LLC, and it is maintained by Sean P. Kane works as a critical care clinical pharmacist and has also developed software. That combination is the main reason to consider it: the person deciding what goes into the database is someone who reads these trials for a living.

The pitch is speed. Instead of pulling up a paper and working through it, you get a short summary of a trial and the details that tend to matter at the bedside. The app is explicit that it does not replace the original manuscript, and I think that framing is right. It is a memory aid and a teaching tool, not a source you would cite in place of the trial itself.

At $4.99 with no ads and no in-app purchases, it sits in the small category of medical apps that ask for money once and then leave you alone. For a clinician who already carries enough subscriptions, that model is easy to appreciate.

What a trial entry actually contains

Each entry opens with a one-line summary of the trial, then moves into what the developer calls key points. Those points cover the inclusion and exclusion criteria, the treatment protocol used, the endpoints the investigators looked at and the findings they reported. That is the core of the app, and it is a sensible structure: the criteria tell you whether the patient in front of you resembles the trial population at all, which is often the first question worth asking.

The entries also carry commentary on subgroup analyses and limitations. This is the part I would value most in a reference like this, because subgroup findings are where trials get misread. A summary that flags where an analysis was exploratory, or where the design left a question open, is more useful than a bare result. The developer describes this commentary as expert, and given the stated background of the app's maintainer, that claim is at least plausible.

What you are not getting is the full paper. Effect sizes, tables and the nuances of the discussion section stay in the original. The app is meant to be read in a few minutes, and the depth of each entry reflects that.

The breadth of the trial database

The database holds more than 150 landmark trials, spread across a wide set of critical care topics. The listed areas include ARDS, cardiac arrest, DVT and PE, delirium, glycemic control, heart failure, hemorrhage, meningitis, nephroprotection, nutrition, pneumonia, sedation, seizure, sepsis and shock, spinal cord injury, stroke, and subarachnoid hemorrhage. That is a broad sweep of the ICU, and it covers the subjects that come up in handover, journal club and board review.

The developer says more trials and topics are being added on a regular basis, and the most recent update backs that up: it refreshed the trial database along with interface and functionality work for current Android versions. For a reference app, staying current is most of the battle, and a database that grows is more useful than one frozen at launch.

The range also makes the app useful beyond the ICU itself. A pharmacy student on a critical care rotation, a resident preparing for a presentation, or a nurse practitioner new to intensive care would all find topics here that match what they are being asked to learn.

Sharing a trial with a colleague

A Share Trial button emails a PubMed link. You can pass a pivotal trial along to a student, a resident or a colleague without leaving the app to look up the citation yourself. It is a small feature, but it fits the way teaching usually happens on a busy service: someone asks for the reference, and you send it while the question is still fresh.

The link is a citation, so the recipient still needs their own access to the full text. That is a reasonable arrangement for a reference tool, and it keeps the app on the right side of the line between summarizing and republishing.

The recent update also improved the Trial of the Day feature and the database update notifications, so there is a light ongoing nudge to look at something new rather than only opening the app when a specific question comes up.

What it costs and what it assumes

ICU Trials is a one-time $4.99 purchase. There are no ads and no in-app purchases, so nothing inside the app is gated behind a further payment. For a working clinician, that is a modest outlay against the time saved looking up trial details.

The app assumes you already have some footing in critical care literature. Entries are written as summaries for people who know what an endpoint is and why an inclusion criterion matters, not as tutorials that build the concepts from scratch. A first-year medical student without ICU exposure would likely find the entries terse, while a fellow or attending would find them efficient.

It also assumes you treat the summaries as a starting point. The developer is clear that the original manuscript remains the authority, and the design reflects that: you get the shape of a trial and its main caveats, and you go to the paper when the decision actually depends on the detail.

Where this fits in a clinician's toolkit

The strongest case for ICU Trials is a clinician who needs to recall a landmark trial quickly and accurately. Someone covering an ICU, teaching on rounds, or preparing for an exam in critical care would get steady use out of a database of this size. The install base of more than 10,000 and the 4.6 average from 227 ratings suggest it has found an audience among people doing exactly that work.

It is not a decision-support tool and does not pretend to be one. It will not tell you what to do for a specific patient, and it will not replace reading the paper when the stakes are high. What it does is compress a large body of critical care evidence into entries you can read in the time it takes to walk to a bedside.

The app has been on Google Play since June 2012, which is a long run for a niche medical reference, and the recent update shows it is still being worked on rather than left as-is. For the price of a single purchase, that track record is a meaningful part of the value.

A worthwhile purchase for ICU clinicians

I would recommend ICU Trials to critical care clinicians, residents, students on an ICU rotation and anyone who teaches from the critical care literature. The combination of a broad trial database, structured key points and commentary on limitations makes it a practical companion to the original papers, and the one-time $4.99 price with no ads or purchases keeps it simple.

The main caveat is that it summarizes rather than reproduces. If you need the full manuscript, you still need the manuscript. But as a fast reference for the trials that shape ICU practice, this is a focused, well-maintained tool that does one job and does it without clutter.

What's new in version 2026.07

Significant UI, functionality updates for the latest version of Android, and the latest trial database. Trial of the Day and database update notifications have also been improved.